F-group (family)
3456.1.1.1 Oxidored_q4
Ligands and drugs
849
Member domains
274
with ligand contacts (≤ 4 Å)
32.3% of members
166
with DrugDomain annotations
19.6% of members
98
with a DrugBank compound
11.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3456.1.1.1 belongs to X-group 3456 NADH-quinone oxidoreductase subunit A, which has 14 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04327 | PEE | Phosphatidylethanolamine | 62 |
| DB03429 | CDL | Tetrastearoyl cardiolipin | 17 |
| DB02338 | NDP | NADPH | 6 |
| DB07640 | DCQ | 2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | 6 |
| DB02043 | LHG | 1,2-Dipalmitoyl-Phosphatidyl-Glycerole | 4 |
| DB02686 | UMQ | Undecyl-Beta-D-Maltopyranoside | 2 |
| DB09270 | U10 | Ubidecarenone | 2 |
| DB03426 | DGD | Digalactosyl Diacyl Glycerol (Dgdg) | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 177 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 123 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 75 |
| PLX | (9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL | 71 |
| CDL | CARDIOLIPIN | 23 |
| PLC | DIUNDECYL PHOSPHATIDYL CHOLINE | 14 |
| U10 | UBIQUINONE-10 | 7 |
| PGT | (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | 6 |
| T7X | Phosphatidylinositol | 6 |
| DGD | DIGALACTOSYL DIACYL GLYCEROL (DGDG) | 5 |
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 5 |
| UQ9 | Ubiquinone-9 | 5 |
| LFA | EICOSANE | 4 |
| LHG | 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE | 4 |
| 3PH | 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE | 3 |
| DU0 | 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol | 3 |
| SQD | 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL | 3 |
| DCQ | 2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | 2 |
| PC7 | (7S)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE | 2 |
| Q7G | 2-{[(4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranosyl)oxy]methyl}-4-{[(3beta,9beta,14beta,17beta,25R)-spirost-5-en-3-yl]oxy}butyl 4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranoside | 2 |